Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke
Go back to Abbott's next-generation Amulet 360™ device receives CE Mark to treat people with atrial fibrillation at risk of stroke| Abbott Laboratories (NYSE: ABT) | Delayed: 102.61 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $102.61 | 52 Week High | $46.38 | |||
| Open | $102.61 | 52 Week Low | $36.00 | |||
| Day High | $102.61 | P/E | 68.41 | |||
| Day Low | $102.61 | EPS | $1.50 | |||
| Volume | 4,977 | |||||
